Cargando…

Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study

BACKGROUND: To compare the effects of adding two different doses of dexamethasone on the duration and quality of the fascia iliaca block in patients undergoing proximal femoral fracture surgery. METHODS: A total of 60 patients (age 18–70 years) undergoing proximal femoral nailing surgery under spina...

Descripción completa

Detalles Bibliográficos
Autores principales: Acharya, Ranjita, Sriramka, Bhavna, Panigrahi, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177541/
https://www.ncbi.nlm.nih.gov/pubmed/30310551
http://dx.doi.org/10.3344/kjp.2018.31.4.261
_version_ 1783361879164321792
author Acharya, Ranjita
Sriramka, Bhavna
Panigrahi, Sandeep
author_facet Acharya, Ranjita
Sriramka, Bhavna
Panigrahi, Sandeep
author_sort Acharya, Ranjita
collection PubMed
description BACKGROUND: To compare the effects of adding two different doses of dexamethasone on the duration and quality of the fascia iliaca block in patients undergoing proximal femoral fracture surgery. METHODS: A total of 60 patients (age 18–70 years) undergoing proximal femoral nailing surgery under spinal anesthesia were given fascia iliaca block after random assignment to one of the two groups: Group H received an injection of levobupivacaine (0.5%) 28 ml with 2 ml (8 mg) dexamethasone, and Group L received an injection of levobupivacaine (0.5%) 28 ml with dexamethasone 1 ml (4 mg) with 1 ml normal saline. Assessment of the duration of analgesia and the total tramadol requirement over 48 hours were noted after a successful block. RESULTS: The duration of analgesia was found to be significantly longer in Group H (17.02 ± 0.45 h) than in the Group L patients (14.29 ± 0.45 h) with a p-value of 0.000. Postoperative analgesic requirement (amount of tramadol in mg) was significantly higher in Group L (Q2: 200.0; IQR: 100.0, 200.0) as compared to Group H (Q2: 100.0; IQR: 100.0, 200.0) with a p-value of 0.034. No patient showed any sign of neurotoxicity. CONCLUSIONS: Dexamethasone, in a dose of 8 mg, is superior to 4 mg when used as an adjuvant with levobupivacaine in the FIB. Though both prolonged analgesia and were effective in reducing oral/intravenous analgesics, 8 mg dexamethasone can be recommended as a more efficacious adjuvant to local anesthetics in the FIB.
format Online
Article
Text
id pubmed-6177541
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Pain Society
record_format MEDLINE/PubMed
spelling pubmed-61775412018-10-11 Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study Acharya, Ranjita Sriramka, Bhavna Panigrahi, Sandeep Korean J Pain Original Article BACKGROUND: To compare the effects of adding two different doses of dexamethasone on the duration and quality of the fascia iliaca block in patients undergoing proximal femoral fracture surgery. METHODS: A total of 60 patients (age 18–70 years) undergoing proximal femoral nailing surgery under spinal anesthesia were given fascia iliaca block after random assignment to one of the two groups: Group H received an injection of levobupivacaine (0.5%) 28 ml with 2 ml (8 mg) dexamethasone, and Group L received an injection of levobupivacaine (0.5%) 28 ml with dexamethasone 1 ml (4 mg) with 1 ml normal saline. Assessment of the duration of analgesia and the total tramadol requirement over 48 hours were noted after a successful block. RESULTS: The duration of analgesia was found to be significantly longer in Group H (17.02 ± 0.45 h) than in the Group L patients (14.29 ± 0.45 h) with a p-value of 0.000. Postoperative analgesic requirement (amount of tramadol in mg) was significantly higher in Group L (Q2: 200.0; IQR: 100.0, 200.0) as compared to Group H (Q2: 100.0; IQR: 100.0, 200.0) with a p-value of 0.034. No patient showed any sign of neurotoxicity. CONCLUSIONS: Dexamethasone, in a dose of 8 mg, is superior to 4 mg when used as an adjuvant with levobupivacaine in the FIB. Though both prolonged analgesia and were effective in reducing oral/intravenous analgesics, 8 mg dexamethasone can be recommended as a more efficacious adjuvant to local anesthetics in the FIB. The Korean Pain Society 2018-10 2018-10-01 /pmc/articles/PMC6177541/ /pubmed/30310551 http://dx.doi.org/10.3344/kjp.2018.31.4.261 Text en Copyright © The Korean Pain Society, 2018 http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Acharya, Ranjita
Sriramka, Bhavna
Panigrahi, Sandeep
Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
title Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
title_full Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
title_fullStr Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
title_full_unstemmed Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
title_short Comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
title_sort comparison of 4 mg dexamethasone versus 8 mg dexamethasone as an adjuvant to levobupivacaine in fascia iliaca block-a prospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177541/
https://www.ncbi.nlm.nih.gov/pubmed/30310551
http://dx.doi.org/10.3344/kjp.2018.31.4.261
work_keys_str_mv AT acharyaranjita comparisonof4mgdexamethasoneversus8mgdexamethasoneasanadjuvanttolevobupivacaineinfasciailiacablockaprospectivestudy
AT sriramkabhavna comparisonof4mgdexamethasoneversus8mgdexamethasoneasanadjuvanttolevobupivacaineinfasciailiacablockaprospectivestudy
AT panigrahisandeep comparisonof4mgdexamethasoneversus8mgdexamethasoneasanadjuvanttolevobupivacaineinfasciailiacablockaprospectivestudy